
### [MONDO:0001700](http://purl.obolibrary.org/obo/MONDO_0001700)
**Label:** megaloblastic anemia (disease)

**Subclasses:** [MONDO:0009853](http://purl.obolibrary.org/obo/MONDO_0009853) (GrC$sbeck-Imerslund disease), [MONDO:0013456](http://purl.obolibrary.org/obo/MONDO_0013456) (constitutional megaloblastic anemia with severe neurologic disease), 

**Corr. equiv. classes:** [Orphanet:35858](http://www.orpha.net/ORDO/Orphanet_35858), [OMIM:261100](http://purl.obolibrary.org/obo/OMIM_261100), [Orphanet:319651](http://www.orpha.net/ORDO/Orphanet_319651), [OMIM:613839](http://purl.obolibrary.org/obo/OMIM_613839), 

**Class expressions from DL-Learner:**

- [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 62.50%
- [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) and [HP:0040195](http://purl.obolibrary.org/obo/HP_0040195) (Decreased head circumference) 62.50%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012448](http://purl.obolibrary.org/obo/HP_0012448) (Delayed myelination) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012447](http://purl.obolibrary.org/obo/HP_0012447) (Abnormal myelination) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012444](http://purl.obolibrary.org/obo/HP_0012444) (Brain atrophy) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0011968](http://purl.obolibrary.org/obo/HP_0011968) (Feeding difficulties) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0025097](http://purl.obolibrary.org/obo/HP_0025097) (Eyelid myoclonus) 62.50%


